Treatment of cardiac failure with an intra aortic balloon pump;Behandling av hjertesvikt med intraaortal ballongpumpe

Tidsskrift for den Norske Laegeforening

Volumn 126, Issue 16, 2006, Pages 2104-2106

  Brunvand, Harald ^a,b   Kongsgård, Erik ^a   Edvardsen, Thor ^a   Simonsen, Svein ^a   Pedersen, Thore H ^a   Karlsen, Harald M ^a   Geiran, Odd ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Medisinsk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; AORTA BALLOON; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE SEPTUM RUPTURE; HOSPITAL DEPARTMENT; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MITRAL VALVE REGURGITATION; MYOCARDITIS; NORWAY; OPERATION DURATION; SURGICAL MORTALITY; UNIVERSITY HOSPITAL; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; CORONARY DISEASE; FEMALE; HEART DISEASES; HEART FAILURE, CONGESTIVE; HUMANS; HYPOTENSION; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 33748049103     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Goldberg RJ, Gore JM, Alpert JS, et al. Cardiogenic shock after acute myocardial infarction: incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 1991; 325: 1117-22.
2. Killip T III, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol 1967; 20: 457-64.
3. Holmes DR jr, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience: the GUSTO-I Investigators: Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995; 26: 668-74.
4. Hochmann JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999; 341: 625-34.
5. Cohen M, Urban P, Christenson JT et al. Intraaortic balloon counterpulsation in US and non-US centres: results of the Benchmark® Registry. Eur Heart J 2003; 24: 1763-1770.
6. Sanborn TA, Sleeper LA, Bates ER et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emerge revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 2000; 36 (3 Suppl A): 1123-9
7. Menon V, Hochman JS, Stebbins A et al. Lack of progress in cardiogenic shock: lessons from the GUSTO trials. Eur Heart J 2000; 21: 1928-36.
8. Waksman R, Weiss AT, Gotsman MS et al. Intraaortic counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarction. Eur Heart J 1993; 14: 1-74
9. Kovack PJ, Rasak MA, Bates ER et al. Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. J Am Coll Cardiol 1997; 29: 1454-8.
10. Arafa OE, Pedersen TH, Svennevig JL et al. Intraaortic balloon pump in open heart operations: 10-year follow-up with risk analysis. Ann Thorac Surg 1998; 65: 741-7.
11. Arafa OE, Pedersen TH, Svennevig JL et al. Vascular complications of the intraaortic balloon pump in patients undergoing open heart operations. 15-year experience. Ann Thorac Surg 1999; 67: 645-51
12. Patel JJ, Kopisyanski C, Boston B et al. Prospective evaluation of complications associated with percutaneous intraaortic balloon counter pulsation. Am J Cardiol 1995; 76: 1205-7.
13. Holmes DR jr, Bates ER, Kleiman NS et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. J Am Coll Cardiol 1995; 26: 668-74
14. Hasdai D, Califf RM, Thompson TD et al. Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 2000; 35: 136-43.
15. Eggum R, Saatvedt K, Brunvand H et al. En 54 år gammel mann med alvorlig sirkulasjonssvikt. TNLF 2005; 125: 1491-92.